Effectiveness of breast-conserving surgery in patients with breast cancer

Эффективность органосохраняющих операций при раке молочной железы
Dinara Amanzholova 1 * , Valentina Sirota 1
More Detail
1 Department of Oncology and Radiodiagnosis, Karaganda Medical University, Karaganda, Republic of Kazakhstan
* Corresponding Author
J CLIN MED KAZ, Volume 1, Issue 51, pp. 8-11. https://doi.org/10.23950/1812-2892-JCMK-00657
OPEN ACCESS 2918 Views 2054 Downloads
Download Full Text (PDF)

ABSTRACT

Contemporary diagnostics methods can suspect the presence of tumors in mammary gland of minimal size. The current world trend in the treatment of breast cancer, especially early breast cancer, is the use of organ conserving treatment as a method that improves patient’s quality of life with preserving mammary glands. This study systematizes results of recent researches which studied long-term results of treatment after radical mastectomy and breast conserving surgery.
Keywords: breast cancer, breast-conserving surgery, mastectomy

CITATION

Amanzholova D, Sirota V. Effectiveness of breast-conserving surgery in patients with breast cancer. Journal of Clinical Medicine of Kazakhstan. 2019;1(51):8-11. https://doi.org/10.23950/1812-2892-JCMK-00657

REFERENCES

  • Litiere S, Werutsky G, Fentiman IS, Rutgers E, Christiaens M-R, Van Limbergen E, et al. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol. 2012; 13(4):412 e9. https://doi.org/10.1016/S1470-2045(12)70042-6
  • Jianyang Wang, Shulian Wang, Yu Tang, et al. Comparison of treatment outcomes with breast-conserving surgery plus radiotherapy versus mastectomy for patients with stage I breast cancer: a propensity score-matched analysis. Clinical Breast Cancer. 2018;18(5):975-84. https://doi.org/10.1016/j.clbc.2018.06.002
  • Simone NL, Dan T, Shih J, Smith SL, Sciuto L, Lita E, et al. Twenty-five year results of the national cancer institute randomized breast conservation trial. Breast Cancer Res Treat. 2012; 132(1):197-203. https://doi.org/10.1007/s10549-011-1867-6
  • Hwang ES, Lichtensztajn DY, Gomez SL, Fowble B, Clarke CA. Survival after lumpectomy and mastectomy for early stage invasive breast cancer: the effect of age and hormone receptor status. Cancer. 2013; 119:1402-11. https://doi.org/10.1002/ cncr.27795
  • Hofvind S, Holen A, Aas T, Roman M, Sebuodegard S, Akslen LA. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics. Eur J Surg Oncol. 2015; 41:1417-22. https://doi.org/10.1016/j.ejso.2015.07.002
  • Olaf Johan Hartmann-Johnsen, Rolf Karesen, Ellen Schlichting and Jan F. Nygard. Better survival after breast-conserving therapy compared to mastectomy when axillary node status is positive in early-stage breast cancer: a registry-based followup study of 6387 Norwegian women participating in screening, primarily operated between 1998 and 2009. World Journal of Surgical Oncology. 2017; 15:118. https://doi.org/10.1186/s12957-017-1184-6
  • Agarwal S, Pappas L, Neumayer L, Kokeny K, Agarwal J. Effect of breast conservation therapy vs mastectomy on diseasespecific survival for early-stage breast cancer. JAMA Surg. 2014; 149(3):267-74. https://doi.org/10.1001/jamasurg.2013.3049
  • van Maaren MC, de Munck L, de Bock GH, Jobsen JJ, van Dalen T, Linn SC, et al. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in The Netherlands: a population-based study. Lancet Oncol. 2016; 17(8):1158 e70. https://doi.org/10.1016/S1470-2045(16)30067-5
  • Mirelle Lagendijk, Marissa C. van Maaren, Sepideh Saadatmand, Luc J.A. Strobbe, Philip M.P. Poortmans, Linetta B. Koppert, Madeleine M.A. Tilanus-Linthorst and Sabine Siesling. Breast conserving therapy and mastectomy revisited: Breast cancerspecific survival and the influence of prognostic factors in 129,692 patients. Int. J. Cancer. 2018; 142:165–175 https://doi. org/10.1002/ijc.31034
  • Cao JQ, Olson RA, Tyldesley SK. Comparison of recurrence and survival rates after breast-conserving therapy and mastectomy in young women with breast cancer. Curr Oncol. 2013; 20(6):e-593-601. https://doi.org/10.3747/co.20.1543 
  • Tian-Jian Yu, Ying-Ying Liu, Xin Hu, Gen-Hong Di. Survival following breast-conserving therapy is equal to that following mastectomy in young women with early-stage invasive lobular carcinoma. European Journal of Surgical Oncology. 2018; 44(11):1703-1707. https://doi.org/10.1016/j.ejso.2018.06.026
  • Jose Vila, Sara Gandini, Oreste Gentilini. Overall survival according to type of surgery in young (≤40 years) early breast cancer patients: A systematic meta-analysis comparing breast-conserving surgery versus mastectomy. The Breast. 2015; 24(3):175- 181. https://doi.org/10.1016/j.breast.2015.02.002
  • Wei X-Q Li X, Xin X-J, Tong Z-S, Zhang S. Clinical features and survival analysis of very young (age <35) breast cancer patients. Asian Pac J Cancer Prev. 2013; 14(10): 5949-52. http://dx.doi.org/10.7314/APJCP.2013.14.10.5949
  • The Korean Breast Cancer Society, Han W, Kang SY. Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer. Breast Cancer Res Treat. 2010; 119(1):193-200. https://doi.org/10.1007/s10549-009-0388-z
  • Biglia N, Maggiorotto F, Liberale V, Bounous VE, Sgro LG, Pecchio S, et al. Clinical-pathologic features, long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC). Eur J Surg Oncol. 2013; 39(5):455 e60. https://doi.org/10.1016/j.ejso.2013.02.007
  • Braunstein LZ, Brock JE, Chen YH, Truong L, Russo AL, Arvold ND, et al. Invasive lobular carcinoma of the breast: local recurrence after breast-conserving therapy by subtype approximation and surgical margin. Breast Cancer Res Treat. 2015; 149(2):555e64. https://doi.org/10.1007/s10549-015-3273-y
  • Garcia-Fernandez A, Lain JM, Chabrera C, Garcia Font M, Fraile M, Barco I, et al. Comparative long-term study of a large series of patients with invasive ductal carcinoma and invasive lobular carcinoma. Loco-regional recurrence, metastasis, and survival. Breast J. 2015; 21(5):533-7. https://doi.org/10.1111/tbj.12455
  • Houssami N, Macaskill P, Marinovich ML, Morrow M. The association of surgical margins and local recurrence in women with early-staged invasive breast cancer treated with breast-conserving therapy: a meta-analysis. Ann Surg Oncol. 2014; 21(3):717- 30. https://doi.org/10.1245/s10434-014-3480-5
  • Freedman RA, He Y, Winer EP, Keating NL. Trends in racial and age disparities in definitive local therapy of early-stage breast cancer. J Clin Oncol. 2009; 27:713-719. https://doi.org/10.1200/JCO.2008.17.9234
  • Katipamula R, Degnim AC, Hoskin T, et al. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol. 2009; 27:4082-8. https://doi.org/10.1200/JCO.2008.19.4225
  • McGuire KP, Santillan AA, Kaur P, et al: Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5685 patients. Ann Surg Oncol. 2009; 16: 2682-2690. https://doi.org/10.1245/s10434- 009-0635-x
  • Sorbrero ME, Dick AW, Beckjord EB, et al: Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy. Ann Surg Oncol. 2009; 16:1597-1605. https://doi.org/10.1245/s10434-009-0362-3
  • Scarlett Lin Gomez, Daphne Lichtensztajn, et al. Increasing mastectomy rates for early-stage breast cancer? Population-based trends from California. J Clin Oncol. 2010; 28(10):e155-e158. https://doi.org/10.1200/JCO.2009.26.1032
  • Lee CN, Chang Y, Adimorah N, Belkora JK, Moy B, Partridge AH, et al. Decision making about surgery for early-stage breast cancer. J Am Coll Surg. 2012; 214:1-10. https://doi.org/10.1016/j.jamcollsurg.2011.09.017
  • N. Johns, J.M. Dixon. Should patients with early breast cancer still be offered the choice of breast conserving surgery or mastectomy? EJSO 42. 2016; 1636-1641. https://doi.org/10.1016/j.ejso.2016.08.016
  • Gu J, Groot G, Boden C, Busch A, Holtslander L, Lim H. Review of Factors Influencing Women’s Choice of Mastectomy Versus Breast Conserving Therapy in Early Stage Breast Cancer: A Systematic Review. Clin Breast Cancer. 2018;18(4):e539-e554. https://doi.org/10.1016/j.clbc.2017.12.013
  • Gu J, Groot G. Creation of a new clinical framework – why women choose mastectomy versus breast conserving therapy. BMC Medical Research Methodology. 2018; 18:77. https://doi.org/10.1186/s12874-018-0533-7
  • S. Fisher H. Gao Y. Yasui K. Dabbs M. Winget. Survival in stage I–III breast cancer patients by surgical treatment in a publicly funded health care system. Annals of Oncology. 2015; 26 (6):1161–1169. https://doi.org/10.1093/annonc/mdv107
  • M.C. van Maaren, L. de Munck, J.J. Jobsen, et al. Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patients. Breast Cancer Res Treat. 2016; 160:511. https://doi.org/10.1007/s10549-016-4012-8
  • D.V. Khaylenko, S.M. Portnoy, Yu.S. Egorov, V.A.Khaylenko. Breast conserving surgery in the treatment of breast cancer stage III. Tumors of female reproductive system. 2016; 12:52-55.